Exchange Traded Concepts’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Exchange Traded Concepts's GILD Position: Q2 2026 in Review
Exchange Traded Concepts increased its Gilead Sciences (GILD) stake by 428% in Q2 2026, buying an estimated $28.5M and bringing the position to 266,845 shares worth $33.7M. The position accounts for 0.15% of the portfolio, ranked #122.
Exchange Traded Concepts first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Exchange Traded Concepts held 266,845 shares of Gilead Sciences worth $33.7M as of Q2 2026.
- Exchange Traded Concepts bought 216,275 Gilead Sciences shares in Q2 2026, an estimated $28.5M.
- Gilead Sciences made up 0.15% of Exchange Traded Concepts's portfolio in Q2 2026, its #122 holding.
- Exchange Traded Concepts first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.